Karyopharm Therapeutics Inc. (KPTI) stock
KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.04−0.01 (-20.00%)
Close on Nov 9, 2026Market cap $1.16KP/E –Yield –
Karyopharm Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Karyopharm Therapeutics's price to sales ratio was 0.0× on Nov 9, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 5.7×, with a median of 0.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 9, 2026 | 0.0× | −0.4 |
| 2025 | Dec 31, 2025 | 0.4× | −0.1 |
| 2024 | Dec 31, 2024 | 0.6× | −0.1 |
| 2023 | Dec 29, 2023 | 0.7× | −0.4 |
| 2022 | Dec 30, 2022 | 1.1× | −3.0 |
| 2021 | Dec 31, 2021 | 4.1× | −8.4 |
| 2020 | Dec 31, 2020 | 12.5× | −39.8 |
| 2019 | Dec 31, 2019 | 52.3× | +34.3 |
| 2018 | Dec 31, 2018 | 18.0× | −208.8 |
| 2014 | Jan 31, 2014 | 226.7× | +77.9 |
| 2013 | Dec 31, 2013 | 148.9× | – |
See a number that looks wrong?